Innate Pharma S.A. (EPA: IPH)
France
· Delayed Price · Currency is EUR 2.090
-0.020 (-0.95%)
Aug 30, 2024, 5:35 PM CET
Innate Pharma Income Statement
Financials in millions EUR. Fiscal year is September - August.
Millions EUR. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '24 Feb 29, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2018 - 2014 |
| Operating Revenue | 330.34 | 276.82 | 219.86 | 202.31 | 172.87 | 207.11 | Upgrade
|
| Other Revenue | 1.18 | 1.52 | 1.53 | 1.66 | 1.69 | 1.92 | Upgrade
|
| Revenue | 331.52 | 278.34 | 221.4 | 203.97 | 174.56 | 209.03 | Upgrade
|
| Revenue Growth (YoY) | 36.80% | 25.72% | 8.55% | 16.85% | -16.49% | 51.11% | Upgrade
|
| Cost of Revenue | 186.31 | 155.41 | 118.27 | 103.51 | 85.89 | 109.1 | Upgrade
|
| Gross Profit | 145.21 | 122.93 | 103.13 | 100.46 | 88.66 | 99.93 | Upgrade
|
| Selling, General & Admin | 108.64 | 94.85 | 77.65 | 68.95 | 64.51 | 73.13 | Upgrade
|
| Other Operating Expenses | -25.37 | -17.38 | -12.28 | -3.07 | 0.78 | -4.45 | Upgrade
|
| Operating Expenses | 97.11 | 89.33 | 77.25 | 77.01 | 76.3 | 79.17 | Upgrade
|
| Operating Income | 48.11 | 33.61 | 25.89 | 23.45 | 12.36 | 20.76 | Upgrade
|
| Interest Expense | -1.16 | -0.73 | -0.92 | -0.74 | -0.9 | -1.12 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.02 | - | 0 | Upgrade
|
| Earnings From Equity Investments | -0.09 | -0.09 | - | -4.85 | -4.51 | -0.42 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.97 | -2.13 | 0.1 | -0.14 | -0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.14 | 2.42 | 0.3 | 0.18 | 0.08 | 0.39 | Upgrade
|
| EBT Excluding Unusual Items | 49.96 | 34.24 | 23.14 | 18.16 | 6.9 | 19.25 | Upgrade
|
| Impairment of Goodwill | -18.25 | -13 | - | - | 0.01 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.1 | 0.1 | 0 | 0.04 | - | - | Upgrade
|
| Asset Writedown | - | - | - | 0.01 | - | -0.11 | Upgrade
|
| Other Unusual Items | -1.62 | -1.49 | 0.07 | 0.26 | 6.01 | -3.02 | Upgrade
|
| Pretax Income | 30.19 | 19.84 | 23.21 | 18.47 | 12.92 | 16.12 | Upgrade
|
| Income Tax Expense | 12.54 | 8.72 | 7.38 | 7.54 | 5.44 | 5.3 | Upgrade
|
| Earnings From Continuing Operations | 17.65 | 11.12 | 15.83 | 10.93 | 7.48 | 10.83 | Upgrade
|
| Minority Interest in Earnings | -0.49 | 0.31 | 0.08 | 0.68 | -0.36 | 0.22 | Upgrade
|
| Net Income | 17.16 | 11.43 | 15.91 | 11.61 | 7.12 | 11.05 | Upgrade
|
| Net Income to Common | 17.16 | 11.43 | 15.91 | 11.61 | 7.12 | 11.05 | Upgrade
|
| Net Income Growth | -4.77% | -28.16% | 37.09% | 63.05% | -35.55% | 6.94% | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 0.08% | 0.00% | -0.09% | 0.03% | 0.07% | 0.01% | Upgrade
|
| EPS (Basic) | 10.30 | 6.86 | 9.55 | 6.96 | 4.27 | 6.63 | Upgrade
|
| EPS (Diluted) | 10.30 | 6.86 | 9.55 | 6.96 | 4.27 | 6.63 | Upgrade
|
| EPS Growth | -4.84% | -28.17% | 37.21% | 63.00% | -35.60% | 6.94% | Upgrade
|
| Free Cash Flow | 3.89 | 19.11 | 46.36 | 51.25 | 13.05 | 15.19 | Upgrade
|
| Free Cash Flow Per Share | 2.33 | 11.47 | 27.82 | 30.74 | 7.83 | 9.12 | Upgrade
|
| Dividend Per Share | 2.200 | 2.200 | 2.030 | 1.850 | 1.680 | 1.680 | Upgrade
|
| Dividend Growth | 8.37% | 8.37% | 9.73% | 10.12% | 0% | 19.15% | Upgrade
|
| Gross Margin | 43.80% | 44.17% | 46.58% | 49.25% | 50.79% | 47.80% | Upgrade
|
| Operating Margin | 14.51% | 12.07% | 11.69% | 11.49% | 7.08% | 9.93% | Upgrade
|
| Profit Margin | 5.18% | 4.11% | 7.19% | 5.69% | 4.08% | 5.28% | Upgrade
|
| Free Cash Flow Margin | 1.17% | 6.87% | 20.94% | 25.13% | 7.48% | 7.27% | Upgrade
|
| EBITDA | 63.32 | 41.73 | 35.25 | 31.9 | 20.82 | 29.93 | Upgrade
|
| EBITDA Margin | 19.10% | 14.99% | 15.92% | 15.64% | 11.93% | 14.32% | Upgrade
|
| D&A For EBITDA | 15.22 | 8.12 | 9.36 | 8.46 | 8.46 | 9.17 | Upgrade
|
| EBIT | 48.11 | 33.61 | 25.89 | 23.45 | 12.36 | 20.76 | Upgrade
|
| EBIT Margin | 14.51% | 12.07% | 11.69% | 11.49% | 7.08% | 9.93% | Upgrade
|
| Effective Tax Rate | 41.55% | 43.94% | 31.79% | 40.84% | 42.14% | 32.85% | Upgrade
|
| Revenue as Reported | 359.41 | 297.95 | 235.86 | 209.59 | 176.29 | 216.35 | Upgrade
|
| Advertising Expenses | - | 4.02 | 2.94 | 1.22 | 3.3 | 3.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.